Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CHALKCAP-835
- Development stage
- Unknown
- Lead developer
- Charoon Bhesaj
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
CHALKCAP-835 is an approved oral calcium supplement containing 835 mg of calcium carbonate (equivalent to 334 mg of elemental calcium), developed and marketed by Charoon Bhesaj Thailand. It functions as a small molecule mineral supplement and phosphate binder. In the gastrointestinal tract, calcium carbonate reacts with dietary phosphate to form insoluble calcium phosphate, which is excreted in the feces, thereby reducing serum phosphate levels in patients with chronic renal failure. Additionally, it serves as a direct source of calcium to maintain calcium homeostasis and treat deficiency states such as hypocalcemia, osteoporosis, rickets, and osteomalacia. It is also indicated for use as an antacid and as a supplement for pregnant, lactating, or postmenopausal women.
- Brand names
- CHALKCAP-835CHALKCAP835CHALKCAP 835CHALKCAP
- Other names
- calcium carbonate 835 mg
02
Targets
Pi (Inorganic phosphate)
Beyond the preview
Go deeper on CHALKCAP-835.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CHALKCAP-835.